Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Select Medical Holdings (SEM) Other financing activities: 2009-2024

Historic Other financing activities for Select Medical Holdings (SEM) over the last 15 years, with FY2024 value amounting to $15.7 million.

  • Select Medical Holdings' Other financing activities fell 4380.12% to $2.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $20.9 million, marking a year-over-year increase of 5585.54%. This contributed to the annual value of $15.7 million for FY2024, which is 3148.9% down from last year.
  • Latest data reveals that Select Medical Holdings reported Other financing activities of $15.7 million as of FY2024, which was down 3148.9% from $22.9 million recorded in FY2023.
  • Select Medical Holdings' Other financing activities' 5-year high stood at $22.9 million during FY2023, with a 5-year trough of $7.6 million in FY2020.
  • Moreover, its 5-year median value for Other financing activities was $15.7 million (2024), whereas its average is $15.3 million.
  • In the last 5 years, Select Medical Holdings' Other financing activities plummeted by 5899.6% in 2020 and then soared by 17408.78% in 2021.
  • Select Medical Holdings' Other financing activities (Annual) stood at $7.6 million in 2020, then soared by 174.09% to $20.7 million in 2021, then plummeted by 54.03% to $9.5 million in 2022, then surged by 140.66% to $22.9 million in 2023, then tumbled by 31.49% to $15.7 million in 2024.
  • Its Other financing activities stands at $15.7 million for FY2024, versus $22.9 million for FY2023 and $9.5 million for FY2022.